September 19, 2001: Issue No. 2.0

The employees of Epocrates would like to recognize the efforts of many of our users living in the greater New York and D.C. areas who have been providing medical support for the injured and their families during this difficult time. We also wish to express our deepest sympathy to the families and friends of our users who have been personally affected by the September 11th tragedies.

We will continue to provide you with any important clinical news related to these events via DocAlert® messages on your mobile device.

Please read on to find out about the latest Epocrates database updates and more.

Be one of the first to know about the next drug recall!

This month's issue includes:
•

AutoUpdate often to get drug updates and important medication safety DocAlerts® such as the recent Baycol® withdrawal announcement

•
Now available - $100 instant credit towards the purchase of an Epocrates branded Palm m500!
•
Nearly a thousand Epocrates users have earned honorariums by participating in the new Epocrates Honors™ Program - Have you opted in yet?
•
Are you using MultiCheck and Regimens and Tables - two of the most useful and unknown Epocrates Rx™ features?
•
Epocrates Advocate of the Month
AutoUpdate often to get drug updates and important medication safety DocAlerts® such as the recent Baycol® withdrawal announcement
Epocrates Rx™ is continually updated - recent drug updates include Advair™ Diskus®, Detrol® LA and more . . .

Since our last newsletter, our clinical board has made hundreds of updates to the Epocrates Rx™ database. These updates are automatically integrated into your Epocrates Rx application every time you AutoUpdate (perform a HotSync® operation while connected to the Internet). Some of our more notable additions include:

New Monographs -- Advair™ Diskus®, NovoLog®, Lumigan™, Rescula®, Quixin™, Geodon™, Lantus®, Travatan® Malarone™, Mifeprex™ and Trizivir®
New Formulations -- Biaxin XL®, Detrol® LA
Withdrawals -- Baycol®

Be the first to hear about important medication alerts from the FDA, the CDC and the ISMP
· We have recently partnered with these leading health and safety organizations so you can receive important medication safety alerts (called Epocrates DocAlerts®) - such as the recent Baycol® withdrawal - directly on your Palm top after you AutoUpdate.

Additional new Epocrates DocAlert® topics include:
· Important news about recent research conducted at leading medical institutions such as the Mayo Clinic and Johns Hopkins
· Notification of recent drug additions to the Epocrates database
· Case questions to test your medical knowledge
· What happened this week in medical history

If you have any suggestions for additional DocAlert® content you would like to see, please email us at docalerts@epocrates.com.

AutoUpdate and download performance is greatly improved!
We have invested significant capital into improving our systems to speed up the AutoUpdate and download processes for you. You may not be aware that the more frequently you AutoUpdate, the shorter the wait times. We recommend you AutoUpdate at least twice a week to have the most current clinical information available.

If you need any technical assistance using AutoUpdate or if you are experiencing wait times of over ten minutes, we encourage you to visit our Web site at http://www.epocrates.com/support/ to access our troubleshooting request form. By using this e-mail form you will provide us enough information to help resolve your problem.Your troubleshooting request will be received by us within minutes, and we generally respond with a suggested solution within 8 business hours.

Now available - $100 instant credit towards the purchase of an Epocrates branded Palm m500!
We are now pleased to offer Epocrates branded Palm m500's at the Epocrates WebStore: https://www.epocrates.com/aff_webstore/

For a limited time, you will be eligible to receive a $100 credit towards the purchase of an Epocrates branded Palm m500 complete with the following features:
· 8MB of memory
· Expandable memory card
· Quick charging lithium ion batteries
· Recharging cradle and USB cable
· Silent alarm (vibration and LED blink modes)
· Unique Epocrates royal blue faceplate
· Stylish and attractive ultra-thin design

You will also receive:

A complementary CD-ROM you can use to install:
· Epocrates Rx™ and Epocrates ID™ software
· MedMath medical calculator
· BabyCalc pregnancy calculator
· Palm Desktop and mobile applications

Complementary support
· Free one stop technical support for the mobile unit, Epocrates software and Palm software
· Warranty return support for the mobile unit

The Epocrates branded Palm m500's normally retails for $449. However, in exchange for agreeing to complete two 15 minute on line surveys, you will receive an instant credit of $100 resulting in a net cost of $349.

If you or your medical organization is interested in purchasing a large quantity of Epocrates branded m500's, please contact affiliates@epocrates.com to find out about our special volume discounts.
Nearly a thousand Epocrates users have earned honorariums by participating in the new Epocrates Honors™ Program - Have you opted in yet?
We would like to thank the physicians who have participated in the Epocrates Honors™ surveys, and also thank those of you who have opted in to participate in the program by updating your user profile accordingly. The Epocrates Honors Program offers users in our network the opportunity to provide their insights on current clinical topics in return for an honorarium, and also helps Epocrates earn revenue so that we can continue to provide you with useful clinical software. If you have not yet opted in, you still have time! Please follow the directions below. Currently the Honors program is only available for physicians; however, in the future, we hope to offer these opportunities to other professionals in our network. If you are not a physician and are interested in future opportunities, we still encourage you to opt in.

If you are interested in participating but are not sure whether you have indicated so in your user profile, please visit our Web site at https://www.epocrates.com/ and click "My Profile" in the upper right hand corner. Next, enter your user name and password, click "edit" in the User Profile box, and make sure the first box is not checked. (This box is labeled "Please do not inform me of opportunities for reimbursement such as participating in market research OR opportunities to assist Epocrates with future product development.") If your profile fits one of the upcoming survey's requirements, we will send you an email invitation to participate. If you have any questions about the Epocrates Honors program, please email honors-support@epocrates.com.
Are you using MultiCheck and Regimens and Tables - two of our most useful and unknown Epocrates Rx™ features?
Do you know how to access all the valuable features in Epocrates Rx™ including MultiCheck and Regimens and Tables (including the latest AHA ACLS and arrhythmia guideline algorithms)?

Accessing MultiCheck - This unique feature allows you to select up to 30 medications and quickly determine if any clinically significant drug interactions exist.

You can access this feature in 2 convenient ways:

Option 1:
· Open Epocrates Rx™ (you must be inside the application to use MultiCheck).
· Tap the Menu button, which is at the bottom left-hand corner of your screen.
· You will see App, Edit and Options at the top left of your screen.
· Select 'App' then "Run MultiCheck."

OR

Option 2: Open Epocrates Rx™, and use the graffiti shortcut: /i

To use MultiCheck, tap on any number of drugs (up to 30) and click Run. The interactions will be displayed. Then, tap on each pairing to view the detailed interaction information between the two drugs. To run another check, tap "New." Otherwise, tap "Close."

Accessing Regimens and Tables - The latest ACLS and arrhythmia guideline algorithms from the AHA are now included in Regimens and Tables. Some other examples of Epocrates Regimens and Tables include:

· Vaccination Schedule, Child
· Formulas, General
· Formulas, Cardiac
· Therapeutic Drug Levels
· Narcotic Equivalents
· Thrombolytic Criteria
· Inhaler Colors
· H. pylori Treatment
· Post-Coital Contraception

Regimens and Tables can be accessed in three different ways:

Option 1 (suggested method):
· Search "By Class"
· Tap "Other"
· Tap "Regimens and Tables"

Option 2:
· Search "By Drug"
· Tap "Tables" (in between Syprine and tacrine)

Option 3: Each of the tables are also individually listed alphabetically within the "By Drug" listing.

We are in the process of creating even more useful tables. After we release them, they will be automatically integrated into your application when you AutoUpdate.

If you would like a visual guide to provide more information about these features and many others, please visit our website and take the Epocrates Rx™ tour by clicking: https://www.epocrates.com/catalog.doEpocratesRx4/tour/.
Epocrates Advocate of the Month
Advocate Program

As part of our effort to spread the word about Epocrates software, we created the Epocrates Advocate Program. This program was designed for those users who are interested in sharing information about Epocrates with colleagues. If you are currently an Epocrates Advocate, we would like to thank you for participating in the Advocate program. If you would like to become an Epocrates Advocate, please write to advocates@epocrates.com.

Advocate of the Month

This month, we have selected Dr. Bill Rose, an emergency physician from Morgantown, West Virginia to be our Advocate of the Month. We would like to thank Dr. Rose for including Epocrates in his recent American College of Emergency Physicians' member newsletter article about the benefits of using mobile technology in his practice.

"Epocrates Rx™ and Epocrates ID™ have been real timesaving tools for my Emergency Medicine practice. On a busy day in the Emergency Department I don't have time to go find a book to look up medications so it is extremely helpful to have Epocrates software immediately available and up-to-date. Patients are really impressed with Multicheck when I check for potential drug interactions at their bedside."

- Dr. Bill Rose

This concludes the September issue of the Epocrates Newsletter. We hope you enjoy using Epocrates medical software, and encourage you to contact us at feedback@epocrates.com if you have any questions or suggestions for improvement. Best wishes! - The Epocrates Team

If you do not want to receive future emails from Epocrates, which will include our communication of drug updates, monthly newsletters, and other Epocrates information, please click https://www.epocrates.com/account.do?mode=summary and modify your user profile by checking the second box that reads, "I do not want to be notified about drug database updates, free future products, or other relevant information from Epocrates."